Understanding the Challenges of Adopting Photobiomodulation Therapy

This chapter explores the reasons behind the slow adoption of photobiomodulation (PBM) therapy as a mainstream treatment, despite numerous studies showing its benefits. It discusses the need for expensive clinical trials, the categorization of PBM as alternative medicine, and the skepticism among physicians. The chapter also delves into the importance of measuring the light dose at target tissues and discusses the systemic effects of PBM therapy, as well as the potential use of artificial intelligence in managing PBM devices.